Trials (and tribulations) of biocompatible peritoneal dialysis fluids.
作者信息
Johnson David W, Cho Yeoungjee, Brown Fiona G
机构信息
Department of Renal Medicine, Princess Alexandra Hospital School of Medicine, University of Queensland, Brisbane, Australia.
出版信息
Perit Dial Int. 2012 May-Jun;32(3):247-51. doi: 10.3747/pdi.2012.00044.
Abstract
摘要
相似文献
1
Trials (and tribulations) of biocompatible peritoneal dialysis fluids.生物相容性腹膜透析液的试验（及磨难）
Perit Dial Int. 2012 May-Jun;32(3):247-51. doi: 10.3747/pdi.2012.00044.
2
Experimental peritoneal dialysis solutions.
Perit Dial Int. 1993;13 Suppl 2:S98-100.
3
Evidence for Biocompatible Peritoneal Dialysis Solutions.生物相容性腹膜透析液的证据
Contrib Nephrol. 2017;189:91-101. doi: 10.1159/000450690. Epub 2016 Dec 12.
4
How to avoid glucose degradation products in peritoneal dialysis fluids.如何避免腹膜透析液中的葡萄糖降解产物。
Perit Dial Int. 2006 Jul-Aug;26(4):490-7.
5
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2014 Mar 27(3):CD007554. doi: 10.1002/14651858.CD007554.pub2.
6
A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.一项关于葡萄糖降解产物低的腹膜透析液的临床和生化特征的研究。
Perit Dial Int. 2012 May-Jun;32(3):280-91. doi: 10.3747/pdi.2010.00176. Epub 2011 Nov 3.
7
Comparison of peritoneal dialysis solutions.
Nephrol Nurs J. 2004 Sep-Oct;31(5):499-507, 520; quiz 508-9.
8
Clinical advantages of new peritoneal dialysis solutions.
Nephrol Dial Transplant. 2002;17 Suppl 3:16-8. doi: 10.1093/ndt/17.suppl_3.16.
9
Prevention of peritoneal sclerosis: a new proposal to substitute glucose with carnitine dialysis solution (biocompatibility testing in vitro and in rabbits).预防腹膜硬化：用肉碱透析液替代葡萄糖的新提议（体外及兔体内生物相容性测试）
Int J Artif Organs. 2005 Feb;28(2):177-87. doi: 10.1177/039139880502800215.
10
Glucose degradation products in peritoneal dialysis fluids: how they can be avoided.
Perit Dial Int. 2001;21 Suppl 3:S119-24.
引用本文的文献
1
Biocompatibility of a new PD solution for Japan, Reguneal™, measured as in vitro proliferation of fibroblasts.一种用于日本的新型腹膜透析溶液Reguneal™的生物相容性，通过成纤维细胞的体外增殖来衡量。
Clin Exp Nephrol. 2018 Dec;22(6):1427-1436. doi: 10.1007/s10157-018-1602-2. Epub 2018 Jun 20.
2
Is the Effect of Low-GDP Solutions on Residual Renal Function Mediated by Fluid State? An Enigmatic Question which Still Needs to be Solved.低GDP溶液对残余肾功能的影响是由液体状态介导的吗？一个仍有待解决的谜之问题。
Perit Dial Int. 2016 May-Jun;36(3):239-42. doi: 10.3747/pdi.2015.00149.
3
The balANZ study--strengthening the evidence for neutral-pH solutions low in glucose degradation products.平衡研究——强化关于低葡萄糖降解产物的中性pH值溶液的证据
Perit Dial Int. 2012 Sep-Oct;32(5):489-92. doi: 10.3747/pdi.2012.00204.
本文引用的文献
1
Biocompatible dialysis fluids for peritoneal dialysis.用于腹膜透析的生物相容性透析液。
Cochrane Database Syst Rev. 2014 Mar 27(3):CD007554. doi: 10.1002/14651858.CD007554.pub2.
2
Effects of biocompatible versus standard fluid on peritoneal dialysis outcomes.生物相容性与标准液对腹膜透析结果的影响。
J Am Soc Nephrol. 2012 Jun;23(6):1097-107. doi: 10.1681/ASN.2011121201. Epub 2012 Mar 22.
3
A new neutral-pH low-GDP peritoneal dialysis fluid.一种新的中性 pH 值、低 GDP 的腹膜透析液。
Perit Dial Int. 2012 Jul-Aug;32(4):444-52. doi: 10.3747/pdi.2011.00072. Epub 2012 Mar 1.
4
A study of the clinical and biochemical profile of peritoneal dialysis fluid low in glucose degradation products.一项关于葡萄糖降解产物低的腹膜透析液的临床和生化特征的研究。
Perit Dial Int. 2012 May-Jun;32(3):280-91. doi: 10.3747/pdi.2010.00176. Epub 2011 Nov 3.
5
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique survival.将患者随机分配到生物相容或常规腹膜透析溶液的长期随访结果显示，腹膜炎或技术生存率无差异。
Kidney Int. 2011 Nov;80(9):986-991. doi: 10.1038/ki.2011.244. Epub 2011 Aug 3.
6
Rationale and design of the balANZ trial: a randomised controlled trial of low GDP, neutral pH versus standard peritoneal dialysis solution for the preservation of residual renal function.平衡试验（balANZ 试验）的原理和设计：一项比较低 GDP、中性 pH 值与标准腹膜透析液对残余肾功能保护作用的随机对照试验。
BMC Nephrol. 2010 Sep 16;11:25. doi: 10.1186/1471-2369-11-25.
7
Low-GDP fluid (Gambrosol trio) attenuates decline of residual renal function in PD patients: a prospective randomized study.低 GDP 液（甘丙肽三联）可减缓 PD 患者残余肾功能下降：一项前瞻性随机研究。
Nephrol Dial Transplant. 2010 Jul;25(7):2288-96. doi: 10.1093/ndt/gfq087. Epub 2010 Mar 1.
8
Biocompatibility and tolerability of a purely bicarbonate-buffered peritoneal dialysis solution.一种纯碳酸氢盐缓冲腹膜透析液的生物相容性和耐受性。
Perit Dial Int. 2009 Nov-Dec;29(6):647-55.
9
Impact of low glucose degradation product bicarbonate/lactate-buffered dialysis solution on the epithelial-mesenchymal transition of peritoneum.低葡萄糖降解产物碳酸氢盐/乳酸盐缓冲透析液对腹膜上皮-间充质转化的影响。
Am J Nephrol. 2010;31(1):58-67. doi: 10.1159/000256658. Epub 2009 Nov 4.
10
Mortality and technique failure in peritoneal dialysis patients using advanced peritoneal dialysis solutions.使用先进腹膜透析液的腹膜透析患者的死亡率和技术失败率
Am J Kidney Dis. 2009 Oct;54(4):711-20. doi: 10.1053/j.ajkd.2009.05.014. Epub 2009 Jul 19.
Zotero 插件